Plasmapheresis and Osteoporosis: The Absence of Evidence Is Not the Evidence of Absence

被引:0
作者
Amrein, K. [1 ]
Dimai, H. P. [1 ]
Dobnig, H. [1 ,2 ]
Fahrleitner-Pammer, A. [1 ]
机构
[1] Med Univ Graz, Univ Klin Innere Med, Klin Abt Endokrinol & Stoffwechsel, Auenbruggerpl 15, A-8036 Graz, Austria
[2] Schilddrusen Endokrinol Osteoporose Inst Dobnig, Graz, Austria
来源
JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN | 2016年 / 23卷 / 02期
关键词
apheresis; plasmapheresis; osteoporosis; bone mineral density; bone turnover markers; hypocalcemia; endocrine disruptors; hyperparathyroidism;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma and the products derived from it are indispensable to modern medicine, e.g. for immunoglobulins, coagulation factors, and albumin. Apheresis donations allow for selective collection of plasma with minimal loss of red blood cells. However, reliable anticoagulation - usually with citrate - is required because of the length and method of the donation procedure. Citrate complexes calcium and therefore leads to acute hypocalcemia, hyperparathyroidism, and prolongation of the QT interval. Apheresis donors also experience exposure to "endocrine disrupting chemicals" such as pthalates, which leak from the plastic donation sets during the donation and have been implicated with potential adverse effects on fertility and endocrine function. Repetitive apheresis might therefore be a previously unknown risk factor for impaired bone health. The existing data are however sparse and insufficient to confirm or reject this hypothesis.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 14 条
  • [1] Adverse events and safety issues in blood donation-A comprehensive review
    Amrein, Karin
    Valentin, Angelika
    Lanzer, Gerhard
    Drexler, Camilla
    [J]. BLOOD REVIEWS, 2012, 26 (01) : 33 - 42
  • [2] Apheresis affects bone and mineral metabolism
    Amrein, Karin
    Katschnig, Claudia
    Sipurzynski, Sabine
    Stojakovic, Tatjana
    Lanzer, Gerhard
    Stach, Elisabeth
    Pieber, Thomas R.
    Dobnig, Harald
    [J]. BONE, 2010, 46 (03) : 789 - 795
  • [3] [Anonymous], NCT00073060
  • [4] [Anonymous], J CLIN APHER
  • [5] Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects
    Bolan, CD
    Cecco, SA
    Yau, YY
    Wesley, RA
    Oblitas, JM
    Rehak, NN
    Leitman, SE
    [J]. TRANSFUSION, 2003, 43 (10) : 1414 - 1422
  • [6] Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms
    Bolan, CD
    Wesley, RA
    Yau, YY
    Cecco, SA
    Starling, J
    Oblitas, JM
    Rehak, NN
    Leitman, SF
    [J]. TRANSFUSION, 2003, 43 (10) : 1403 - 1413
  • [7] Bone density in apheresis donors and whole blood donors
    Boot, C. L.
    Luken, J. S.
    van den Burg, P. J. M.
    de Kort, W. L. A. M.
    Koopman, M. M. W.
    Vrielink, H.
    van Schoor, N. M.
    den Heijer, M.
    Lips, P.
    [J]. VOX SANGUINIS, 2015, 109 (04) : 410 - 413
  • [8] Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis
    Buchta, C
    Bittner, C
    Höcker, P
    Macher, M
    Schmid, R
    Seger, C
    Dettke, M
    [J]. TRANSFUSION, 2003, 43 (08) : 1115 - 1120
  • [9] Effect of acute citrate load on markers of bone metabolism in healthy volunteers
    Chen, Y.
    Bieglmayer, C.
    Hoecker, P.
    Dettke, M.
    [J]. VOX SANGUINIS, 2009, 97 (04) : 324 - 329
  • [10] Calcium supplementation attenuates citrate-related changes placebo-controlled crossover study in healthy volunteers
    Chen, Ying
    Hou, Jianming
    Chen, Guolong
    Lin, Hao
    Lin, Hongkeng
    Chu, Xiaoling
    Zheng, Jia
    Chen, Cen
    Lin, Juan
    Dettke, Markus
    [J]. BONE, 2011, 49 (03) : 506 - 512